CAS 2095849-04-8

CSF1R-IN-1

CAS : 2095849-04-8

CSF1R-IN-1 is a CSF1R inhibitor with IC50 of 0.5 nM.

Formule : C₂₅H₂₀F₃N₅O₂

Degré de pureté : 97.02% - 98.56%

Couleur et forme : Solid

Masse moléculaire : 479.45

Ref: TM-T10894

CSF1R-IN-1

CAS : 2095849-04-8

Formule : C₂₅H₂₀F₃N₅O₂

Degré de pureté : 99%

Masse moléculaire : 479.4538

Ref: IN-DA01N148

CSF1R-IN-1

CAS : 2095849-04-8

CSF1R-IN-1

Degré de pureté : ≥95%

Masse moléculaire : 479.45g/mol

Ref: 54-BUP07026

5-(1-Methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamide

CAS : 2095849-04-8

5-(1-Methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamide

Degré de pureté : 99%

Masse moléculaire : 479.45g/mol

Ref: 54-PC108760

CSF1R-IN-1

CAS : 2095849-04-8

CSF1R-IN-1 is a small molecule inhibitor, which is derived from synthetic chemical processes designed to selectively target the colony-stimulating factor 1 receptor (CSF1R) tyrosine kinase. The primary mode of action of CSF1R-IN-1 involves the inhibition of the CSF1R signaling pathway. This pathway is crucial for the regulation of the development and function of macrophages, which are vital for immune response and homeostasis. By selectively binding to the ATP-binding site of CSF1R, CSF1R-IN-1 effectively blocks the receptor's activity, thus reducing unwanted macrophage-mediated inflammation and proliferation.

Formule : C₂₅H₂₀F₃N₅O₂

Degré de pureté : Min. 95%

Masse moléculaire : 479.5 g/mol

Ref: 3D-VID84904